Project Grant HT9425261E241
Award Date 7/1/26
Completion Date 6/30/30
Dollars Obligated $2.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $501,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 15, 2025, with a completion date of July 14, 2027. The research project, titled "Large Oncosomes as Drivers of Prostate Cancer Bone Metastasis," is being conducted at the institution's West Hollywood, California location. This award supports biomedical...
- Cedars-Sinai Medical Center will receive $501,000 through a two-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support the medical center's research project "CD44 Enhances Efficacy of the Chimeric Antigen Receptor T-Cell Therapy Against Prostate Cancer." Through this funding, Cedars-Sinai researchers will investigate using CD44 to improve the effectiveness of CAR T-cell therapy in treating...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $1.25M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2025, with a performance period through September 29, 2029. The award supports research investigating the structure, function, and inhibition of ONECUT2 as a driver of prostate cancer. This research initiative aligns with the DHA's broader portfolio of biomedical...
- This Project Grant award, totaling $2,685,519.00, was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cedars-Sinai Medical Center in West Hollywood, CA. The grant supports advanced biomedical research to define human correlates of super-evasive disseminated tumor cells, assess their pathological relevance, and explore methods to eradicate them. This 4-year research project, running from July 1, 2025 to June 30, 2029, aims to...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $600,000 project grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) with an award date of May 1, 2026, and completion date of April 30, 2030. The research project, titled "From H & E to HRD: Linking Morphometry, Clinical, and Molecular Data for Drug Response Prediction," will be conducted at the Medical Center's West Hollywood,...
- The Defense Health Agency awarded a $598,130 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. Specifically, the project will investigate the "Determinants of Lung Cancer-Associated Cachexia" over the period from February 15, 2025 to February 14, 2027. As a leading research...
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $6.15 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of August 1, 2025 through July 31, 2028. The grant supports therapeutic development of a noncoding RNA drug designated TY1 for the treatment of scleroderma. This research initiative represents translational drug development work within DHA's broader portfolio of biomedical...
- The U.S. Department of Defense awarded a $1,000,000.00 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420) to evaluate short- and long-term systemic anti-tumor immunity following combined radiation and immunotherapy in triple-negative breast cancer. This 4-year research project, which commenced on Sep 15, 2023 and is scheduled for completion by Sep 14, 2027, aims to investigate medical solutions for transforming healthcare for...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $839,537 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period May 1, 2026 through April 30, 2028. The award supports research on targeted base editing to alleviate disease pathology in C9ORF72 gene-associated amyotrophic lateral sclerosis (ALS). This research initiative delivers therapeutic development and translational medicine...
- This $4,089,970 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Cedars-Sinai Medical Center to investigate spatial reprogramming of tumor immune microenvironments through preoperative radiotherapy and immune checkpoint inhibition in HER2 negative breast cancer. The award will fund basic, translational, and clinical research over 4 years from September 2023 to August 2027 to develop new treatments,...